{"id":"W4405616616","doi":"10.3802/jgo.2025.36.e51","title":"Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80)","year":2024,"lang":"en","type":"article","venue":"Journal of Gynecologic Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Research Foundation of Korea; Medical Research Council; PharmaMar; Eisai; Amgen; National University of Singapore; National Research Foundation; Chugai Pharmaceutical; Seagen; MacroGenics; Sierra Oncology; Incyte; BeiGene; Clovis Oncology; AstraZeneca; Novocure; Ministry of Science and ICT, South Korea; Kimberly-Clark; Regeneron Pharmaceuticals; Mersana Therapeutics; National Medical Research Council; Karyopharm Therapeutics; Sanofi; GlaxoSmithKline","keywords":"Medicine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Carcinoma; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001966059,0.0004753181,0.003044046,0.000567699,0.0001051954,0.00002961418,0.0002742818,0.0003902502,0.002129412],"category_scores_gemma":[0.0006031982,0.0002663709,0.0004197213,0.0006506928,0.0002608404,0.0001453971,0.0001051806,0.001009833,0.00001519803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001741142,"about_ca_system_score_gemma":0.001481377,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008710583,"about_ca_topic_score_gemma":0.0005067054,"domain_scores_codex":[0.9957367,0.0006689004,0.00187037,0.0005686473,0.0005764171,0.0005789828],"domain_scores_gemma":[0.9934542,0.004568659,0.001010799,0.0003547108,0.0003284914,0.000283123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7741522,0.07127146,0.005804458,0.0002539061,0.001912549,0.01706167,0.005304331,0.0001144015,0.0005331011,0.0000495254,0.002326395,0.1212161],"study_design_scores_gemma":[0.6424084,0.3304433,0.01707583,0.0001437022,0.001604129,0.0004105358,0.002824693,0.000510876,0.0006758289,0.00005210555,0.003588826,0.0002617099],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886238,0.00180299,0.00003568188,0.003283394,0.001621195,0.002656078,0.00001663726,0.0000292428,0.001930971],"genre_scores_gemma":[0.9959693,0.001055109,0.001984489,0.0002855287,0.0002859526,0.0001948086,0.000009318312,0.00004575661,0.0001697272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2591719,"threshold_uncertainty_score":0.9999788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03196311436663559,"score_gpt":0.3535288015074919,"score_spread":0.3215656871408563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}